Evaluation of metabolic profile of users of hormonal and non-hormonal contraceptives during five years follow-up
Were eligible for the study 489 Women, followed in Federal University of São Paulo Family Planning Service, who used the same contraceptive method during five year of follow-up, According to the service protocol, the patients, after had participated of a orientation group about contraceptives methods, elected one of them. After that, if the choice had been according to the eligibility criteria of World Health Organization, it was approved by a gynecologist. The contraceptive methods available were the intrauterine device (IUD) oral contraceptives, including combined pills and progestin-only formulations, and depot medroxyprogestereone acetate. The study consisted in the evaluation of their medical records of weight, BMI, Blood pressure, glycemia, seric levels of cholesterol and triglycerides, during the five years, and in the comparison of the differences of these data between the contraceptive methods.
Study Type
OBSERVATIONAL
Enrollment
489
Use of Intrauterine device during the follow-up period
Use of combined oral contraceptive during the follow-up period
Use of progestin-only pills during the follow-up period
Federal University of Sao Paulo - Unifesp
São Paulo, São Paulo, Brazil
Body Mass Index
evaluation of variation of body mass index during the usage of hormonal and non-hormonal contraceptives
Time frame: five years follow-up
glycemia
evaluation of variation of glycemia during the usage of hormonal and non-hormonal contraceptives
Time frame: five years follow-up
cholesterol level
evaluation of variation of cholesterol serum levels during the usage of hormonal and non-hormonal contraceptives
Time frame: five years follow-up
triglycerides level
evaluation of variation of triglycerides serum levels during the usage of hormonal and non-hormonal contraceptives
Time frame: five years follow-up
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Use of depot-medroxyprogesterone acetato during the follow-up period